Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia.
about
Generative-discriminative basis learning for medical imagingSpatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairmentPreclinical Alzheimer disease: identification of cases at risk among cognitively intact older individualsA systems approach to stress, stressors and resilience in humansUsing support vector machines with multiple indices of diffusion for automated classification of mild cognitive impairmentThe Global Alzheimer's Association Interactive NetworkSharing data in the global alzheimer's association interactive networkHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadeMeasuring the thickness of the human cerebral cortex from magnetic resonance imagesHigh-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairmentAtrophy rates accelerate in amnestic mild cognitive impairment.Neuroanatomic substrates of late-life mental disorders.Magnetic resonance imaging and magnetic resonance spectroscopy in dementiasAdvances in longitudinal studies of amnestic mild cognitive impairment and Alzheimer's disease based on multi-modal MRI techniques.Imaging of Alzheimer's disease.Attempted and successful compensation in preclinical and early manifest neurodegeneration - a review of task FMRI studiesSpatial component analysis of MRI data for Alzheimer's disease diagnosis: a Bayesian network approach.MR-based in vivo hippocampal volumetrics: 1. Review of methodologies currently employed.MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders.Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease.Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.The role of biomarkers in clinical trials for Alzheimer diseaseMagnetic resonance imaging of Alzheimer's disease.Stereological analysis of neuron, glial and endothelial cell numbers in the human amygdaloid complex.Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study.Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease.Prognostic value of posteromedial cortex deactivation in mild cognitive impairment.Longitudinal rates of lobar atrophy in frontotemporal dementia, semantic dementia, and Alzheimer's disease.Collaborative computational anatomy: an MRI morphometry study of the human brain via diffeomorphic metric mappingSerum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart StudyRate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function.Structural imaging in early pre-states of dementia.Brain imaging in the study of Alzheimer's diseasePreventing dementia.Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classificationMulti-atlas based representations for Alzheimer's disease diagnosis.Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention.Hippocampal and amygdalar volumes in dissociative identity disorder.Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.
P2860
Q24630139-4B89CD2F-5C23-4C3E-BA8F-53CA8CF32824Q24630962-CD1C119E-345F-4998-9267-23C324569BA9Q24648319-093D2C74-91E0-4EA6-ADC1-4DE7B65BA94BQ26995405-50FEDB02-999D-4472-8DB6-7F45DE2CB5B6Q27006797-77F30221-72F7-4E20-B773-D9E76012FF1DQ28481248-30215623-D111-43D3-AF99-EAEE6065299CQ28601466-0BE63B6F-E2D1-4A4E-AE40-0A0798E1CE16Q28607247-9EB716AC-1120-441D-ADFC-614CFA656F9DQ29614407-1B3D4650-3A17-4A4B-8D78-19019C795DE6Q29615080-90849447-7D2C-40AD-B065-F6197305C145Q30487873-9D8F8504-D058-43A4-8F19-43F322FA5DFFQ30489846-E277BE1C-3D4E-4883-B13F-CB9A06C83935Q30585266-D90D83B5-0EF3-4CF7-B3BF-384455D5B6E1Q30660816-488C0C5C-5D6F-4BEF-9833-AB0A371E06C6Q30765803-6B5A7F48-7B90-4D48-9A1F-ACFB44144DE4Q30815106-5397779D-990D-439E-B117-33F0F5B5D797Q30862037-7ED8B8D8-AE9E-4F1B-986A-94B87F813876Q30878103-E64D733F-5885-4ED4-B555-0908FB0E9E9CQ30955567-638108F0-818A-4BFB-B11B-977E34176BE9Q30957247-5399422D-4471-424D-A7BF-7144E9FAA2A6Q30983010-79C1F704-67FD-484C-9E64-057F343A1D5FQ30988163-FFBE3CF8-FA12-43C4-AF47-6C12B4570A10Q31032781-865760FF-DF62-43D0-A754-B2C0BFBED980Q31049661-EEC8C7D0-5D4F-4B4A-AC23-6557B077DB10Q31066630-A783233F-81D7-4E6B-ABE0-E60AEBF86118Q31152078-74AF226F-1310-475D-BD0C-AEAA82E0EE37Q32091544-09D6D67B-C174-421B-A95C-AABBC33284D8Q33304443-4102DA39-ABB6-4C90-99C1-85EA0FA5B93FQ33721825-8E822CD3-5AEB-4B3F-B937-4AA90EB6C31AQ33750292-67D015BB-63EE-43DF-84AC-ED3372CBFD83Q33750609-D3BD1D1E-E689-4DD1-AD0B-402504A0842FQ33862397-34F49CD0-C89E-4B26-A99E-A6A7B9A29EB8Q33967561-3AC1C452-1839-44DC-BE1A-DB92B7AD2C0FQ34102331-C53F4714-B9A9-4D1F-B94B-F2CF54B84227Q34174220-950D6052-BA53-40DF-A41C-A3555D7943FBQ34183016-B5496484-AE77-4A17-813C-CCFCF08FBB52Q34214344-8C25D001-74DB-42F8-B670-313737417D98Q34303501-CE3CC201-D868-4AD6-BBD7-358D825BB7FFQ34508760-A5B13B0B-35C5-4DD8-8A3F-CCCA49465FFDQ34570703-30594467-C5D5-408C-8E2D-DC6AC2E7E4AF
P2860
Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Volume loss of the hippocampus ...... destined to develop dementia.
@en
type
label
Volume loss of the hippocampus ...... destined to develop dementia.
@en
prefLabel
Volume loss of the hippocampus ...... destined to develop dementia.
@en
P2093
P356
P1433
P1476
Volume loss of the hippocampus ...... destined to develop dementia.
@en
P2093
Camicioli R
Howieson D
P304
P356
10.1212/WNL.48.5.1297
P407
P577
1997-05-01T00:00:00Z